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What’s that gene (or protein)? Online resources 
for exploring functions of genes, transcripts, and 
proteins
James R. A. Hutchins
Institute of Human Genetics, Centre National de la Recherche Scientifique (CNRS), 34396 Montpellier, France
ABSTRACT The genomic era has enabled research projects that use approaches including 
genome-scale screens, microarray analysis, next-generation sequencing, and mass spectrom-
etry–based proteomics to discover genes and proteins involved in biological processes. Such 
methods generate data sets of gene, transcript, or protein hits that researchers wish to ex-
plore to understand their properties and functions and thus their possible roles in biological 
systems of interest. Recent years have seen a profusion of Internet-based resources to aid this 
process. This review takes the viewpoint of the curious biologist wishing to explore the prop-
erties of protein-coding genes and their products, identified using genome-based technolo-
gies. Ten key questions are asked about each hit, addressing functions, phenotypes, expres-
sion, evolutionary conservation, disease association, protein structure, interactors, 
posttranslational modifications, and inhibitors. Answers are provided by presenting the latest 
publicly available resources, together with methods for hit-specific and data set–wide infor-
mation retrieval, suited to any genome-based analytical technique and experimental species. 
The utility of these resources is demonstrated for 20 factors regulating cell proliferation. Re-
sults obtained using some of these are discussed in more depth using the p53 tumor suppres-
sor as an example. This flexible and universally applicable approach for characterizing ex-
perimental hits helps researchers to maximize the potential of their projects for biological 
discovery.
INTROduCTION
The past decade has witnessed huge advances in the power and 
scope of analytical technologies based on genomic data. These 
methods, which include the functional identification of genes using 
traditional genetic and RNA interference (RNAi)-based knockdown 
screens (Forsburg, 2001; Boutros and Ahringer, 2008), the identifica-
tion of DNA and RNA populations by microarray analysis or next-
generation sequencing (Capaldi, 2010; Niedringhaus et al., 2011; 
Ozsolak and Milos, 2011), and the identification of proteins, com-
plexes, and their modifications using mass spectrometry–based 
proteomics (Walther and Mann, 2010), have transformed biological 
research. Many researchers can now turn to these techniques to ad-
dress specific biological questions or, by performing larger-scale or 
high-throughput experiments, discover genes, transcripts, and pro-
teins involved in their system of interest.
Although these technologies differ greatly in their principles 
and mechanistics, their general approaches share a similar form. A 
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tionally, resulting in the identification of 
multiple gene, transcript, or protein hits, 
that is, entries from public sequence data-
bases, each described using a unique iden-
tifier code (ID; in some cases known as an 
accession code), plus other data pertinent 
to the experiment in question, such as a 
confidence score or intensity measurement. 
The resulting hits table may typically un-
dergo further bioinformatic analyses, includ-
ing statistical validation, ranking, and, in 
some cases, identification and removal of 
known contaminant entries.
Unfortunately, this hits table is often 
where platform-driven analysis stops, leav-
ing the research biologist with a list of often 
unfamiliar gene, transcript, or protein 
names, abbreviations, and IDs, of which he 
or she has the task of making sense. Re-
searchers faced with such a list will naturally 
be curious to find out more about each of 
the hits, to determine whether they are in-
teresting and worthy of investing time and 
resources for follow-up studies. They may 
wish to know whether the hit was previously 
reported to have an involvement in their bi-
ological system of interest or whether it is 
novel and what is known about its functions, 
structure, interactions, and so on.
Fortunately, help is at hand. The past de-
cade has also seen the emergence of a 
plethora of high-quality database resources 
providing information about the functions of 
genes, transcripts, and proteins for many or-
ganisms. These provide multiple gateways 
for the biologist, allowing access to informa-
tion relating to nucleotide or amino acid se-
quences, genomic origins, evolutionary 
conservation, expression in cells and tissues, 
and association with disease processes. Fur-
ther protein-related information centers on 
enzymatic or other functions, biological pro-
cesses in which they are involved, domain 
and three-dimensional structures, interac-
tion partners, posttranslational modifica-
tions, and the possibility of modulating their 
activities using small-molecule inhibitors.
Database resources providing such in-
formation are necessarily based on gene, 
(less commonly) transcript, or protein IDs. 
Analytical outputs generate hit lists of usu-
ally one ID type. However, types of ID can 
be interconverted (albeit not always per-
fectly), meaning that the resources available 
for consultation are not restricted by the ID 
type generated by the analysis, allowing the data-mining net to be 
cast as widely as possible. Thus a gene function database should 
be considered of equal relevance for exploring the roles of protein 
hits as a protein-based resource. Conversely, a protein domain 
structure database should be considered of equal interest for inves-
tigating potential functions of the products of gene- or transcript-
based hits as a gene-based resource.
typical workflow (Figure 1) involves first the careful isolation of DNA, 
RNA, or proteins from the biological sample of interest, followed by 
a quality control step. The subsequent analysis increasingly depends 
on highly specialized instrumentation and technical expertise and is 
usually performed not by biologists themselves but by analytical 
platforms within core facilities of institutes or outsourced to external 
companies. Raw data from these analyses are analyzed computa-
FIGURE 1: Generalized workflow for the analysis of DNA, RNA, or protein samples and 
questions about the hits identified. Nucleic acid or protein samples isolated from the biological 
material of interest are processed, then analyzed by various methods. Raw analytical data are 
then matched to entries in public databases, generating a results table listing the genes, 
transcripts, or proteins (hits) identified. For each of these hits, 10 questions relating to their 
features, functions, and other properties are shown (blue boxes). Each question is addressed by 
a section in the text, plus one or more supplemental tables containing examples of hyperlinks to 
entries in online resources.
Analysis of processed sample: data acquisition
(e.g. sequencing, microarray analysis, or mass spectrometry).
Sample processing
Sample quality control
(yield, purity)
nucleic acid or
protein sequences
Data analysis: identification of “hits” (genes,
transcripts, or proteins), with confidence scores.
Raw data file(s)
Public databases
Biological
material
Bioinformatic analysis:
statistical validation, ranking,
contaminant filtering.
Hits (genes, transcripts or proteins),
each with a unique identifier code
(ID) and analysis-specific data.
Results table
Sequence &
genomic origins
Gene expression
Drugs & inhibitors Summary & overview
Homologues
& evolution
Genetic variants &
disease association
Question 2
Supplemental Tables S4, S5, S6 & S7
Question 1
Supplemental Tables S1, S2 & S3
Question 4
Supplemental Table S9
Question 7
Supplemental Table S13
Question 9
Supplemental Table S16
Question 10
Supplemental Tables S17 & S18
Question 3
Supplemental Table S8
Post-translational
modifications
Question 6
Supplemental Table S12
Protein-protein
interactions
Protein structure
Question 5
Supplemental Tables S10 & S11
Question 8
Supplemental Tables S14 & S15
Isolation of DNA, RNA or proteins.
Sample for analysis
Functions, pathways
& systems
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database from which hits can be identified on the basis of experi-
mental data. As sequence databases become more comprehensive, 
genome (or proteome) coverage alone will no longer become the 
principal criterion for making such choices; the quality of annotation 
and user experience may also contribute to decisions regarding 
which sequence databases are preferred.
Nucleotide sequence–based hits
The longest-established repositories of nucleotide sequences are 
GenBank (Benson et al., 2014), the European Molecular Biology 
Laboratory Nucleotide Sequence Database (EMBL-Bank), which is 
part of the European Nucleotide Archive (ENA; Pakseresht et al., 
2014), and the DNA Data Bank of Japan (DDBJ) (Kosuge et al., 
2014). These resources collaborate to share sequence information, 
so that all GenBank/EMBL/DDBJ entries can be retrieved from each 
of the host websites. The Reference Sequence (RefSeq) database 
(Pruitt et al., 2014) aims to provide a single entry for each nucleic 
acid or protein molecule, making explicit the relationships between 
genes, transcripts, and proteins. GenBank/EMBL/DDBJ and RefSeq 
entries are stored in the Nucleotide database of the National 
Center for Biotechnology Information (NCBI; NCBI Resource Coor-
dinators, 2014), making this an ideal home database for accessing 
nucleotide entries of these types.
The Ensembl resource (Flicek et al., 2014) comprises sequences 
of genomic DNA, transcripts, and predicted polypeptide products, 
with data originating from genome sequencing projects, mostly 
from vertebrates. Updated versions are released on an approxi-
mately quarterly basis to incorporate genome reassemblies and the 
integration of new sequence and annotation data; this ensures that 
the database continues to improve in reliability, although one down-
side is that Ensembl IDs periodically become outdated and re-
placed. The main Ensembl resource is complemented by the 
Ensembl Genomes database (Kersey et al., 2014), comprising en-
tries from sequenced bacteria, fungi, plants, protists, and inverte-
brate Metazoa (Supplemental Table S3).
For species whose genomes have not been completely se-
quenced (e.g., Xenopus laevis), Gene Indices (Lee et al., 2005) are 
a useful source of sequence information. Here multiple transcripts 
are assembled into tentative consensus sequences that can be used 
as references for gene expression or (following in silico translation) 
proteomics studies.
Protein hits
For protein sequences, the UniProt resource (UniProt Consortium, 
2014) comprises entries from the curated Swiss-Prot and the noncu-
rated TrEMBL (translated EMBL nucleotide) databases. Entries from 
both use UniProt IDs (known as accession codes), which present a 
standard nomenclature used by the majority of protein-oriented 
programs and resources. Swiss-Prot, sometimes referred to as the 
gold-standard protein database, combines stable IDs with rich, ex-
pert-curated annotation relating to the protein’s composition and 
biological functions. TrEMBL entries derive from automatically in 
silico–translated nucleotide entries from the ENA and Ensembl da-
tabases but lack functional annotation. With new versions being re-
leased approximately monthly, the UniProt resource manages to 
combine the best of both worlds: rich annotation together with reg-
ularly updated entries. An additional advantage of UniProt is that for 
most entries, official gene symbols are included in the protein entry 
headings, providing a means for gene- as well as protein-oriented 
database resources to be directly accessed.
Another protein resource of note is the NCBI’s nonredundant 
(nr) database, compiled from entries originating from GenBank/
This review aims to contribute toward satisfying the desires of 
research biologists to explore the functions of protein-encoding 
genes and their transcripts and products. Ten questions are posed 
to guide the characterization of a given hit, each question being 
answered by the presentation of one or more Internet-based re-
sources that provide reliable and relevant information, are freely ac-
cessible, and are described in peer-reviewed publications. Resources 
are included on the basis of quality, comprehensiveness, and usabil-
ity. Another important parameter is that hit-specific entries in these 
resources should be directly accessible via standard gene, transcript, 
or protein IDs.
Each answer is accompanied by Web links to specific entries 
(“deep links”) in relevant databases, presented in the accompany-
ing supplemental tables. The utility of these resources is illustrated 
using a hypothetical data set of 20 factors that regulate aspects of 
cell proliferation. Of these, particular focus is drawn to DNA poly-
merase (Kornberg, 1990), the cyclin-dependent kinase Cdk1 (Dorée 
and Hunt, 2002), and the tumor suppressor p53 (Lane et al., 2010), 
at least one being present in all organisms, enabling the outputs of 
various resources to be compared.
Straightforward methods are also described for biologists to ac-
cess these resources by generating one-click links from results 
spreadsheets directly to database entries and by supplementing re-
sults tables with information to annotate each hit. These approaches 
provide an efficient and flexible means for biologists working with 
any genome-based technology and experimental species to retrieve 
reliable information to enhance biological discovery without the 
need for bioinformatic training, programming experience, or spe-
cialist software.
QuESTION 1: WHAT IS THE SEQuENCE Of THE HIT, 
ANd WHAT ARE ITS gENOmIC ORIgINS?
Hits from screens and analytical experiments may be in the form of 
genes (identified by unique codes, names, or symbols) or nucle-
otide or amino acid sequences (identified by unique IDs). In either 
case, it is often worthwhile to visit the relevant page of the home 
database, that is, the primary or official repository of information 
about that hit, before embarking on visits to online resources of 
more specific functional information.
For gene-based experimental hits from model organisms, the 
home database would be the corresponding species-specific gene 
database (Supplemental Table S1). Here gene pages can be ac-
cessed using species-specific gene nomenclature and codes, which 
may differ from those used by major sequence databases, with the 
majority also being directly accessible using sequence IDs of stan-
dard types. Species-specific gene databases allow rapid access to 
information about genotypes, phenotypes, and the availability of 
mutant strains and related resources, making these preferred first 
ports of call for gene-based studies.
For sequence-based hits, the relevant home database would be 
the primary repository for the sequence (Supplemental Table S2). 
Visiting such a resource allows the biologist to touch base with the 
experimental origins of the sequence and identify the research team 
or project from which the data originate. These resources also allow 
rapid retrieval of nucleotide or amino acid sequences in FASTA and 
other standard formats, which, although unlikely to shed light on 
questions of gene or protein function, is useful for bioinformatic pro-
cedures for which direct linking is not possible. Which site is consid-
ered the home database depends on the source of the sequence 
information used in the analysis. However, this logic also works in 
reverse: for several analytical techniques, the research biologist (or 
the analyst, at the biologist’s direction) has a choice of sequence 
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include the following. For enzymes: substrates and products and 
molecules that modulate their activity, such as allosteric activators 
and cofactors; for structural proteins: the relevant cellular structures 
and partner molecules with which they collaborate to maintain the 
structure; for signaling molecules: upstream regulators and down-
stream targets, plus other components, such as scaffold proteins; 
and for gene expression modulators: members of protein com-
plexes that modulate chromatin and affect transcription. Contextual 
information could include the following. For enzymes: metabolic 
pathways in which they are involved; for structural proteins: the role 
of the structure in the life of the cell; for signaling pathways: an over-
view of relevant pathways, from initial stimuli to ultimate responses; 
and for gene expression regulators: their roles during differentiation 
and development. For all proteins, information about the location(s) 
within or outside of the cells in which they function is of great inter-
est and relevance. Online resources may provide such information in 
a variety of means, ranging from a single word, a line of text, a para-
graph, a summary diagram, or a full-length review article.
Literature searching and functional summaries
One obvious possible starting point for the retrieval of known func-
tions of a gene or protein of interest is a search of the biomedical 
literature, using tools such as PubMed, Google Scholar, and others 
(Lu, 2011; Supplemental Table S4). However, this can result in the 
retrieval of hundreds of titles, linked to abstracts but not necessarily 
full-text articles. A more efficient strategy is to extract pertinent sen-
tences from publications using “smart” literature-mining tools such 
as Textpresso for model organisms (Müller et al., 2004) and iHOP 
(Fernandez et al., 2007). Although a helpful step forward, these 
tools still leave the user with typically dozens (or hundreds) of dis-
connected sentences to sift through and interpret. More convenient 
still would be a concise executive summary of the known properties 
of the gene or protein. Entries in the NCBI Gene database (NCBI 
Resource Coordinators, 2014) contain, for better-characterized 
genes, a single-paragraph summary of the functions of the gene 
product in its physiological and (if relevant) pathological context. 
Similarly, the curated (Swiss-Prot) entries in UniProt have a General 
annotation (Comments) section in which functions, activity, subunit 
structure, and other properties are listed, broken down into catego-
ries, and well referenced. For human genes, more extensive expert-
curated information is provided by the Online Mendelian Inheri-
tance in Man (OMIM) resource (Amberger et al., 2011). Entries here 
contain well-referenced descriptions of the identification of the 
gene and its functions, allelic variants and association with disease, 
and the biochemical properties of the product. OMIM entries can 
also be retrieved by searching with gene identifiers for nonhuman 
model organisms.
Ontology resources
One widely used approach to the functional characterization of 
gene products is the use of controlled-vocabulary ontology terms 
(Supplemental Table S5). This allows hits to be compared, sorted, 
and grouped on the basis of their properties. The Gene Ontology 
(GO) project (Blake, 2013) uses three categories of ontology term—
molecular function, biological process, and cellular component—
based on data from gene or protein resources and published litera-
ture. GO classification has a hierarchical structure, terms being 
applicable at different levels. For a given hit, an interactive hierarchi-
cal GO graph is viewable at Ensembl (within the transcript-based 
display). A detailed listing of all applicable GO terms for a factor of 
interest is rapidly accessible from QuickGO (Huntley et al., 2009), 
although this comprehensive output often contains considerable 
EMBL/DDBJ, RefSeq, Swiss-Prot, and protein-structure databases. 
Entries, which are accessible from the NCBI protein portal (NCBI 
Resource Coordinators, 2014), all have two IDs: one from the data-
base of origin, plus a GenInfo Identifier (GI) number. Combining 
entries in this way, nr has the advantage of being very comprehen-
sive in its coverage, but it has disadvantages such as the rapid turn-
over of GI numbers, inconsistency in nomenclature between source 
databases, and poor functional annotation.
A protein database that achieved popularity among proteomics 
researchers was the International Protein Index (IPI; Kersey et al., 
2004); however, in 2011 this was discontinued and entries integrated 
into UniProt (Griss et al., 2011). The removal in 2014 of IPI cross-
references in UniProt entries finally rendered the IPI obsolete.
Genomic context
For hits of any type, users may wish to access information about the 
genomic contexts of the relevant genes, including chromosomal lo-
cation, gene length and orientation, proximal genes, and relevant 
genomic features in the vicinity. Many species-specific gene data-
bases contain an embedded genome viewer presenting concise 
genomic information, and often this is sufficient. However, when 
more detailed information is required, including multiple alignments 
with other sequences and features, direct access to the relevant lo-
cus within a specialized genome browser is desirable. Probably the 
most comprehensive cross-species tool for visualizing and aligning 
sequences in their genomic contexts is the UCSC Genome Browser 
(Karolchik et al., 2014), which can be queried using all major gene, 
transcript, or protein IDs. Here a diagram shows the gene’s location 
within the relevant chromosome, and, below, a panel presents a 
graphical view of the relevant genomic region, with a multiple align-
ment of various sequences, including splice-variant mRNAs and ex-
pressed sequence tags, features such as single-nucleotide polymor-
phisms (SNPs) and repeats, and features derived from ENCODE 
project data (Rosenbloom et al., 2013). Also shown are multiple 
alignments between the gene of interest and orthologues from re-
lated species. A complementary functionality is provided by the ge-
nome browser within Ensembl, with flexible options for the export 
of genomic sequence data.
Because navigation and exploration of genomes are not the 
themes of this review, for further information readers are directed to 
the Nature Genetics free online series of tutorials, “A user’s guide to 
the human genome” (Wolfsberg et al., 2002). Although these guides 
may be a little outdated and human-centric, the principles remain 
unchanged and are applicable to the navigation of genomes of 
many organisms.
QuESTION 2: WHAT ARE THE kNOWN fuNCTIONS 
Of THE gENE ANd ITS PROduCTS?
This question is probably the most significant of them all: what is the 
gene of interest for, what does its product do, and in what processes 
is it involved? Given the complexity of biological systems, these 
straightforward questions often yield diverse and incomplete sets of 
answers.
One of the first paradigms in molecular biology was the “one 
gene, one enzyme” hypothesis (Horowitz, 1995), and although this 
proved to be a great oversimplification, many gene-product hits 
from screens may correspond to proteins with characterized enzy-
matic activities. Many other proteins may have structural functions 
or play roles in signaling pathways or regulating gene expression. In 
each of these cases researchers will be interested to retrieve essen-
tial information plus contextual information relating to the functions 
of the hits identified in their experiment. Essential information would 
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accessing information on the involvement of molecules in biological 
systems, with data originating from resources including KEGG, Re-
actome, and others. A BioSystems search first generates a list of 
systems in which the gene product plays a role, with headings that 
may range from the extremely general (e.g., “intracellular”) to the 
very specific (e.g., “CDT1 association with the CDC6:ORC:origin 
complex”). Selection of a heading opens a page containing a one-
paragraph description of the system, a pathway diagram (where ap-
propriate), and a multitabbed section providing links to relevant 
genes and proteins and to related biological systems.
Project-specific databases
Functional information more relevant to a particular biological pro-
cess can in some cases be obtained from Web-based databases 
created to disseminate data generated by specific research projects 
(Supplemental Table S7). Data from genome-scale knockout or 
knockdown projects are particularly relevant, as users can be almost 
certain to obtain some functional information relating to their genes 
of interest: at least whether they are essential for viability, plus obvi-
ous and more subtle loss-of-function phenotypes. A pioneering ex-
ample of this is PhenoBank, which describes and shows movies of 
phenotypes obtained from a genome-wide RNAi-knockdown screen 
in Caenorhabditis elegans early embryos (Sönnichsen et al., 2005). 
Another such resource is the Schizosaccharomyces pombe gene da-
tabase, PomBase (Wood et al., 2012), which records phenotypes 
obtained from a genome-wide deletion screen (Kim et al., 2010; 
Hayles et al., 2013).
The MitoCheck database, based on human genes, shows mov-
ies of time-lapse fluorescence microscopy experiments, as well as 
inferred phenotypes, from genome-scale RNAi screens. Initially cre-
ated to record the effects of human gene knockdowns on chromo-
some behavior during the cell cycle (Neumann et al., 2010), this re-
source is being complemented by data sets from subsequent RNAi 
screens investigating additional cellular processes. Also included 
are data on the subcellular localization and protein interactions of 
gene products required for cell division (Hutchins et al., 2010). The 
MitoCheck database can be searched using human gene symbols, 
synonyms, or UniProt IDs, plus gene terms for orthologous nonhu-
man genes, making this a unique and valuable cross-species func-
tional resource.
QuESTION 3: WHAT HOmOLOguES Of THIS gENE 
(OR PROTEIN) ARE kNOWN? HOW WELL HAS IT BEEN 
CONSERVEd THROugH EVOLuTION?
There are several reasons for wanting to identify genes or proteins 
of closely related sequence to the one of interest. First, for a poorly 
annotated transcript or protein (e.g., one with a sequence ID but no 
gene information) the issue may simply be one of identification: an 
identical (or virtually identical) sequence from the same species may 
provide sufficient information to allow gene identification and fur-
ther exploration. Second, for a hit originating from a less well-anno-
tated database, orthologues from closely related species may pro-
vide richer functional annotation and greater availability of research 
resources (including mutant strains, recombinant proteins, and anti-
bodies) for follow-up studies. Third, knowing the extent of conserva-
tion of the gene through evolution indicates how fundamental its 
role is: genes well conserved throughout the kingdom of life likely 
play central roles in vital cell processes, whereas those with more 
limited conservation likely have more specialized roles in certain 
classes of organism.
When considering homologous genes or proteins, the distinc-
tion between orthologues (in which sequence divergence follows 
redundancy. It is often more desirable to represent each GO cate-
gory by one or very few concise terms, so-called GO slims, but these 
are curated and accessed independently of the main GO project. 
PANTHER (Mi et al., 2013) is a resource that classifies proteins from 
82 organisms based on evolutionary relationships. Curated func-
tional information is provided for genes, transcripts, and proteins in 
the form of “slim” terms for the three GO categories plus two func-
tional categories of its own: Protein class and Pathway.
Although undoubtedly helpful, there are notable drawbacks to 
using ontology terms to characterize gene products. First, the high 
rate of research output makes it difficult for assignment of terms to 
keep pace. Second, in several cases, terms are inferred from those 
of orthologous proteins, introducing assumptions that may not 
always hold true. Third, ontology labels largely fail to capture the 
dynamic nature of proteins during the life of a cell or organism. For 
example, a protein may be cytoplasmic in interphase, nuclear in 
prophase, associate with the mitotic spindle in metaphase, and be 
rapidly degraded in anaphase; recording such dynamic behavior is 
crucial for understanding this protein’s function but would not be 
reflected by the corresponding ontology terms.
Enzymes, signaling pathways, and systems
Where it is clear from summary information or ontology annotation 
that the gene product of interest has enzymatic activity, researchers 
may wish to dig deeper to find out more about the enzyme: its 
known substrates, products, and means of regulation. For this, spe-
cialized enzyme information resources can be rapidly accessed and 
are worth visiting (Supplemental Table S6). The IntEnz resource 
(Fleischmann et al., 2004) is home to the official Enzyme Commis-
sion nomenclature; its website provides a clear overview of reac-
tions catalyzed by each enzyme and lists other relevant molecules 
such as cofactors. For more detailed enzymatic information, 
BRENDA (Schomburg et al., 2013) presents an extremely compre-
hensive resource, each enzyme record having subsections relating 
to structure, enzyme–ligand interactions, inhibitors and activating 
molecules, catalytic parameters, and reaction conditions. Also re-
corded is information relating to the cloning, expression, purifica-
tion, and engineering of the enzyme, plus connections with 
disease.
For proteins with roles in signaling pathways, a pathway diagram 
showing at a glance the role of the protein of interest can be a help-
ful starting point. One of the original resources providing informa-
tion in this format is BioCarta Pathways (Nishimura, 2001), with its 
colorful, cartoon-like (but expert-curated) pathway diagrams. Com-
plementing these are the more electrical circuit–like diagrams of the 
Kyoto Encyclopedia of Genes and Genomes (KEGG) PATHWAY re-
source (Kanehisa et al., 2014). On both of these sites, clicking a pro-
tein component within the diagram links to gene- or protein-specific 
information.
The most comprehensive resource encompassing enzymes and 
signaling molecules in their cellular contexts is Reactome (Croft 
et al., 2014). Here molecules small and large are recorded together 
with characterized “events,” which include enzymatic reactions, in-
termolecular binding, and intracellular transport. Querying Reactome 
lists reactions and pathways involving the molecule in question; click-
ing one of these opens an interactive, zoomable diagram of the reac-
tion or pathway, in the context of cellular compartments and mem-
branes, with steps involving the queried gene product highlighted.
Accompanying the rise of systems biology approaches 
(Kirschner, 2005), a systems-based means to retrieving information 
on gene and protein function can also be useful. The NCBI’s 
BioSystems resource (Geer et al., 2010) presents a single portal for 
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displays a rooted, scaled phylogenetic tree in which each of the 
nodes (Ensembl genes) is labeled with gene name and species, to-
gether with a domain diagram of the corresponding protein.
QuESTION 4: HOW IS THIS gENE ExPRESSEd IN CELLS 
OR TISSuES, ANd HOW dOES THIS CHANgE uNdER 
ExPERImENTAL CONdITIONS?
Valuable indications as to the potential involvement of a gene in a 
biological process of interest can be obtained from data relating to 
its pattern of expression within the organism and how this changes 
during development or in response to cell stress or drug treatment 
conditions. For experimental model organisms, summaries of gene 
expression in physiological contexts relevant to that species are 
most often included in the species-specific gene databases; those 
listed in Supplemental Table S1 all have “expression” data sections, 
except for SGD (budding yeast), for which expression data are 
hosted by the SPELL database (Hibbs et al., 2007; Supplemental 
Table S9).
Because the major high-throughput gene expression technolo-
gies (microarray analysis and next-generation sequencing) are nu-
cleic acid based, the majority of expression data are at the transcrip-
tional level. The two largest repositories of gene expression data 
obtained with such technologies are the NCBI’s Gene Expression 
Omnibus (GEO; Barrett et al., 2013) and the European Bioinformat-
ics Institute (EBI)–hosted ArrayExpress (Rustici et al., 2013), which 
also imports GEO entries. These resources provide public access to 
billions of expression data entries, together with corresponding ex-
perimental details. However, with so much data available, instead of 
accessing potentially hundreds of experimental records correspond-
ing to a particular gene, it is almost always preferable to obtain an 
overview of the relevant data first. This facility is admirably provided 
by the EBI’s Gene Expression Atlas (Petryszak et al., 2014), a gene-
oriented database containing a curated subset of ArrayExpress 
data, accessible using virtually all gene, nucleotide, or protein IDs. 
Subsections summarize expression of the selected gene in tissues 
(for some species accompanied by a diagram of the organism with 
expressing tissues highlighted), by cell types, cell lines, and disease 
states, and in response to drug and other experimental treatments. 
Results are provided with links to the original data at ArrayExpress.
For expression detected at the protein level, The Human Pro-
tein Atlas (Asplund et al., 2012) contains image-based data from 
immunohistochemical and immunocytochemical analyses for thou-
sands of human gene products. Each gene page summarizes the 
subcellular location of its product and provides relative quantifica-
tions of antibody staining (from negative to strong) across a range of 
normal tissues and organs, cancer tissues, and cell lines. Clicking a 
summary result leads to a detailed page of staining data, and then 
to high-resolution micrograph images. In each case, full information 
about the antibody used is provided.
QuESTION 5: WHAT IS THE COmPOSITION Of THE 
PROTEIN, IN TERmS Of dOmAINS, SEQuENCE mOTIfS, 
OR THREE-dImENSIONAL STRuCTuRE?
Domains and sequence motifs
For a gene or protein with which one is unfamiliar, a visual overview 
of conserved domains and functional sites in the protein can give 
useful insights, for example, into catalytic activities, binding of co-
factors and interaction partners, and subcellular localization. Some 
of these properties are conferred by larger protein domains, well 
conserved in terms of sequence and structure, whereas other func-
tions depend on short linear motifs (SLiMs) of just a few amino acids 
in length (Hunt, 1990). Domains and motifs within many proteins 
speciation) and paralogues (in which divergence follows gene dupli-
cation) should be borne in mind (Fitch, 2000). For many genes or 
proteins, homologues of both types have been identified by auto-
mated methods, together with inferences about their evolutionary 
history. However, for the many gene products whose sequence con-
servation is low or patchy, formal identification of orthologues and 
paralogues is a highly skilled task, the domain of specialist 
bioinformaticians.
From a gene or protein of interest, one can quickly identify 
known orthologues and paralogues via Ensembl (Supplemental 
Table S8). Each Ensembl gene page contains links to an orthologue 
page and a paralogue page, and then to pairwise alignments of 
cDNA and protein sequences. Although these orthologues and par-
alogues are based on Ensembl IDs, the pages themselves can be 
accessed directly via a variety of gene, nucleotide, and protein ID 
types. The MitoCheck database, searchable using human and non-
human gene names, lists Ensembl-predicted paralogues and ortho-
logues in a concise format, the latter being linked to species-specific 
gene databases where appropriate.
HomoloGene (NCBI Resource Coordinators, 2014) is the NCBI’s 
resource for automated retrieval of gene and protein homologues 
from 21 completely sequenced genomes. Querying by gene sym-
bol or NCBI-based nucleotide or protein ID generates a list of gene 
orthologues, alongside each being a corresponding orthologous 
protein (all based on RefSeq entries), with a graphical representation 
of conserved domains. Links from this page include those to a mul-
tiple sequence alignment, a table of pairwise alignment scores, and 
literature references. An additional useful feature of HomoloGene is 
its statement on evolutionary conservation—for example, “gene 
conserved in fungi/metazoa group.”
For those wanting to perform de novo searches for entries with 
very similar nucleotide or protein sequences to hits of interest, prob-
ably the best-known method is the BLAST algorithm (Altschul et al., 
1990). BLAST searches can be launched via direct Web links from 
the NCBI and UniProt websites for nucleotide or protein hits, re-
spectively, with matches typically listed in decreasing order of qual-
ity. Because searches such as BLAST are relatively processor inten-
sive and can take a few minutes to complete, a more efficient 
approach is to retrieve identified lists of proteins that share a mini-
mum sequence identity. When one has a protein or nucleotide entry 
and wants to identify a set of closely related proteins from any spe-
cies, a very fast and direct method is the UniProt Reference Clusters 
(UniRef) facility (Suzek et al., 2007). UniRef can display a list (“clus-
ter”) of UniProt entries, from all species, whose sequences share at 
least 50%, at least 90%, or 100% identity to the query. In cases in 
which the name of the hit is obscure or a gene identifier is absent, 
accessing UniRef (e.g., at the 90% identity level) quickly displays the 
set of highly similar proteins, some of which may be better anno-
tated than the query. However, UniRef listings lack information about 
which entries within the cluster have the closest identity to the pro-
tein of interest, making this utility unsuitable to judge which protein 
is the closest homologue in the same or other species.
One graphical approach to the identification of gene or protein 
homologues in their evolutionary context is the phylogenetic tree. 
TreeFam (Schreiber et al., 2014) allows rapid access to phylogenetic 
trees representing families of related genes from genome-se-
quenced animals (plus budding and fission yeasts, two flagellates, 
and Arabidopsis as an outgroup set of reference species). Querying 
by gene or protein ID selects the appropriate gene family, for which 
information is presented in two views. The Summary view displays a 
highly compact tree showing the extent of conservation of genes 
from the family within various taxonomic ranks. The Gene Tree view 
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The ANNIE protein sequence annotation and interpretation en-
vironment (Ooi et al., 2009) runs >20 search algorithms in parallel on 
an input sequence to identify compositional and secondary struc-
tural features and matches to various SLiMs and other sequence 
motifs. Protein domains are identified by real-time searches using 
the HMMER, IMPALA, and RPS-BLAST algorithms. A unique feature 
of this resource is its Interactive View display environment: within 
the graphical multialignment, mousing over any identified feature 
reveals more information about that match and its quality, whereas 
“dragging over” a segment allows the user to zoom in on a region 
of interest—if desired, all the way to the amino acid sequence.
Three-dimensional structures
Because a protein’s structure provides the key to understanding the 
mechanism of its function, insights can often be gained by exploring 
structures, especially for proteins complexed with physiologically 
relevant molecules such as interacting proteins or peptides, nucleic 
acids, substrates or cofactors, or small-molecule inhibitors. The de-
finitive resource for protein 3D structures is the Protein Data Bank 
(PDB), for which records can be readily retrieved from the Research 
Collaboratory for Structural Bioinformatics (RCSB) website (Rose 
et al., 2013), its partner site PDB in Europe (PDBe; Gutmanas et al., 
2014), and the NCBI’s Molecular Modeling Database (MMDB; 
Madej et al., 2012; Supplemental Table S11). These resources offer 
complementary search and display options, but all allow the inspec-
tion of structures online using interactive Web-based viewers and 
the download of structure data files for offline viewing using the lat-
est 3D-structure exploration software.
In many cases there are multiple PDB records for a given protein; 
these often correspond to protein constructs of different lengths 
and proteins complexed with different molecules. Searching the 
foregoing resources by gene or protein ID yields the set of relevant 
records, each title being a brief description of the protein plus any 
complexed molecules. Alternatively, a graphical overview of PDB 
records corresponding to a given gene product is provided by 
PDBsum (de Beer et al., 2014). Here a domain diagram of the full-
length protein is shown, and immediately below, a graphical align-
ment of constructs whose structures have been solved, with second-
ary structural elements depicted schematically. For a given construct, 
clicking its schematic diagram opens a sequence alignment with the 
full-length protein, whereas clicking its PDB code opens a page dis-
playing a wealth of structural, biochemical, and functional informa-
tion, with links to structure viewers and to downloading the structure 
file.
Returning to DASty, this program cleverly integrates sequence-
based domain and feature prediction with 3D modeling. When a 
protein’s 3D structure is available, this appears above the graphical 
multialignment in an interactive Jmol viewer (Herraez, 2006), allow-
ing zooming in and out, rotation, and display in different formats. 
Clicking a domain or feature within the alignment highlights corre-
sponding residues within the primary sequence and on the 3D struc-
ture, allowing researchers to identify 3D juxtapositions of domains 
and features within the protein.
QuESTION 6: WHICH PROTEIN INTERACTION PARTNERS 
HAVE BEEN REPORTEd fOR THIS gENE PROduCT?
Following the maxim “by your friends shall you be known,” further 
understanding of a protein’s functions may be gained by identifying 
other proteins with which it interacts. It is increasingly recognized 
that most cellular processes are controlled by proteins acting in the 
context of complexes or “molecular machines” (Alberts, 1998) 
and that the specificity and coordination of intracellular signaling 
have been identified and reported in published studies, and many 
of them are included in curated UniProt entries. However, for a 
more comprehensive coverage of such features, one should turn to 
specialist resources, which use automated sequence or structure-
based classification algorithms, in some cases complemented by 
manual curation.
Several resources providing for the identification of protein do-
mains have been developed; these differ in approaches, definitions, 
and algorithms, thus generating complementary sets of classifica-
tions. Major protein-domain resources driven primarily by sequence 
data include Pfam (Finn et al., 2014), SMART (Letunic et al., 2012), 
PANTHER (Mi et al., 2013), and InterPro (Hunter et al., 2012; Sup-
plemental Table S10). In contrast, domain classification by 
CATH-Gene3D (Sillitoe et al., 2013; Lees et al., 2014) is driven 
mainly by protein three-dimensional (3D) structure data, including 
the overall architecture, subdomain folding, and secondary struc-
tural elements. Programs for identifying SLiMs within a protein of 
interest include PROSITE (Sigrist et al., 2013), the Eukaryotic Linear 
Motif (ELM) database (Dinkel et al., 2014), Minimotif Miner (Mi 
et al., 2012), and Scansite (Obenauer et al., 2003).
Each of these domain or motif identification resources can be 
accessed independently. However, a more efficient approach is to 
employ a program that uses several methods and generates a 
graphical output integrating all identified features in a single dis-
play. Typically with these programs, “mousing over” a feature trig-
gers a pop-up box providing further information. The ideal program 
would use all of the foregoing domain and motif identification 
methods, generating a single clear and concise diagram; because 
no single program includes all of these methods, the prominent re-
sources are described separately.
The NCBI’s Conserved Domain Database (CDD; Marchler-Bauer 
et al., 2013) generates a very compact diagram representing super-
families, domains, and functional sites of the protein, together with 
annotation of specific residues required for activities such as enzy-
matic catalysis or binding to DNA. Parameters used to define 
matches can be refined to allow identification of features at differ-
ent sensitivity thresholds. Mousing over a feature opens a box pro-
viding a functional description and (where available) a 3D structure 
image. Proteins harboring similar domain architectures can be dis-
played via a single-click link to the CDART website (Geer et al., 
2002). The CDD is thus an excellent starting point for identifying 
key features of a protein, before using other programs to perform 
deeper exploration.
The InterPro resource (Hunter et al., 2012) identifies protein fea-
tures in four categories: families, domains, repeats, and sites, based 
on signatures defined by multiple partner databases. The outputs 
are displayed in a clear graphical multialignment, each feature hit 
being a Web link to the relevant entry in the home resource. DASty 
(Villaveces et al., 2011) uses the Distributed Annotation System to 
delegate protein feature annotation to different servers in parallel. 
The protein’s complete amino acid sequence is shown, and below, a 
graphical multialignment shows features returned from various 
sources. These include InterPro domains, structural elements, and 
functional sites manually curated by UniProt, plus a selection of pre-
dicted SLiMs. The ELM functional site prediction tool (Dinkel et al., 
2014) displays Pfam and SMART domains, globular and ordered (or 
disordered) regions, and secondary structural elements, plus a large 
battery of SLiMs, both from sequence-based predictions and cu-
rated from the literature, in a graphical multialignment format. Be-
low the protein feature diagram, a table provides detailed informa-
tion on the sequence segments corresponding to features in the 
display.
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to exist runs into the hundreds (UniProt lists >450) and continues to 
increase. Because several residues within a protein may potentially 
be modified, with different PTMs present in various combinations, 
the potential repertoire of distinct species of modified protein in a 
cell is astronomical.
The modification status of a protein is highly dynamic, in many 
cases depending on the activities of enzymes that catalyze the addi-
tion and removal of the PTMs, those of proteins that bind depend-
ing on modification status, and the relative colocalization of all these 
players within the cell—sometimes to different parts of an organelle. 
These properties often in turn depend on cellular contexts such as 
cell type, cell-cycle phase, and cellular stresses, including drug treat-
ments. Thus researchers wanting to know whether their gene prod-
uct of interest is modified in vivo need to take into consideration this 
biological and experimental contextual information; the storage 
and retrieval of these metadata poses a particular challenge for PTM 
databases.
Hundreds of proteins have been the subject of focused PTM-re-
lated publications, and UniProt makes a major effort to incorporate 
these findings into its reviewed (Swiss-Prot) entries. For better-char-
acterized proteins, the Post-translational modification subsection of 
UniProt’s General annotation (Comments) reports which residues 
are known to be modified, which enzymes catalyze these modifica-
tions (where identified), and their functional consequences, with lit-
erature links. The power of modern mass spectrometry–based pro-
teomics to identify, with high confidence and on a fairly large scale, 
several (but certainly not all) PTMs in proteins isolated from cells or 
tissues (Young et al., 2010) means that modifications identified from 
more-focused studies can be complemented by high-quality PTM 
data sets from larger-scale studies. However, whereas the resultant 
data explosion can be readily accommodated by specialist PTM da-
tabases, those protein resources that rely on manual curation to en-
sure quality are likely to lag behind in terms of up-to-dateness.
Arguably the most extensively studied protein PTM is the phos-
phorylation of tyrosine, serine, and threonine residues, and protein 
phosphorylation resources have taken the lead regarding the cura-
tion of PTM data and their retrieval with the necessary contextual 
information (Supplemental Table S13). The most comprehensive of 
these is PhosphoSitePlus (Hornbeck et al., 2012), in which each pro-
tein record includes a functional summary, and then modification 
sites (phosphorylation, plus several other types) are shown graphi-
cally in the context of the protein’s domains. An accompanying table 
lists PTM sites with their surrounding amino acid sequences, com-
paring those from orthologous proteins in related species. Each 
modified residue has its own record page, displaying experimental 
and contextual information and literature references. Complemen-
tary information on protein phosphorylation is provided by the 
Phospho.ELM (Dinkel et al., 2011) and PHOSIDA (Gnad et al., 2011) 
resources.
Several databases include information about specific PTM types, 
but trawling though each individually would be an unnecessarily te-
dious exercise. A more efficient approach is to search a meta-data-
base, one bringing together data originating from several separate 
databases. For PTM-related information the most comprehensive 
resource is dbPTM (Lu et al., 2013), whose entries cover 96 types of 
modification and originate from UniProt, with specialist databases of 
PTMs including protein phosphorylation, glycosylation, S-nitrosyla-
tion, ubiquitylation, and methylation, plus their own literature text-
mining efforts. Here the location of each experimentally determined 
PTM is shown in a protein-domain diagram; beneath is a table listing 
the PTMs with some sequence context, Web links to the databases 
of origin, and literature references.
pathways is due to a large degree to interactions between signaling 
molecules and scaffold proteins (Good et al., 2011). Thus informa-
tion about interactions of gene products can provide useful physio-
logical context to understanding their biological functions.
Numerous protein–protein interaction databases have been de-
veloped, and thus a plethora of information is accessible, with a 
variety of options for retrieval and display (Supplemental Table S12). 
Some standardization between these resources is being achieved, 
as 12 prominent interaction databases have joined the International 
Molecular Exchange (IMEx) consortium to share curation and an-
notation of interaction data (Orchard et al., 2012). IntAct (Orchard 
et al., 2014) and BioGRID (Chatr-Aryamontri et al., 2013) are both 
IMEx-member protein–protein interaction resources that display in-
teractions initially in a table format, with options for these to be 
displayed graphically. In the IntAct results table, the protein of inter-
est (molecule A) appears next to information about each interacting 
protein (molecule B), including methods by which interaction was 
established (e.g., tandem affinity purification or two-hybrid assay), 
with links to literature references. The Graph tab generates a simple 
interactive interaction diagram, centered on molecule A. In BioGRID, 
gene products interacting with the protein of interest are tabulated 
in two formats: an uncluttered Summary, listing interactors by gene 
symbol, with synonyms and one-line descriptions; and a Sortable 
Table, listing the species, types of experiment used to establish in-
teraction, and links to literature. The Graphical Viewer button opens 
a radial interaction diagram centered on the molecule of interest, 
with multiple options including filtering out interactions from low- or 
high-throughput studies or those discovered by different experi-
mental approaches.
The STRING resource (Franceschini et al., 2013) generates by 
default a colorful interactive network diagram centered on the pro-
tein of interest, surrounded by its interacting partners. Each interact-
ing protein is represented by a colored ball, labeled by gene sym-
bol. Clicking each ball opens an information box containing a 
description, domain, and (where available) 3D structure; clicking an 
edge (connecting line) opens a box detailing the evidence for that 
interaction. Because STRING defines “interaction” based on diverse 
criteria, including “experiments” (such as coprecipitation or yeast 
two-hybrid assays), “coexpression,” and “textmining,” care should 
be exercised in interpreting the network diagram to ensure that in-
teractions shown are of a type relevant to the issue in question. This 
can be achieved via the color coding of the network edges by inter-
action type, and a filter can be applied to restrict displayed interac-
tions to those of a certain type—for example, “experiments.”
Interaction databases are invaluable resources for providing in-
formation about known partners and networks in which the gene 
products are involved. However, protein–protein interactions are 
certainly not always constitutive, and cell contexts—for example, 
cell-cycle and developmental stages and responses to stresses—
count for a great deal. Currently, as with ontology terms, these dy-
namic aspects are rarely conveyed by interaction databases, leaving 
room for future developments to these resources.
QuESTION 7: WHAT POSTTRANSLATIONAL 
mOdIfICATIONS HAVE BEEN REPORTEd fOR THIS 
PROTEIN?
The covalent addition of chemical moieties to the side chains of 
particular amino acid residues is a highly prevalent and versatile 
mechanism by which proteins are regulated in both eukaryotes and 
prokaryotes (Walsh, 2006; Deribe et al., 2010) and likely plays im-
portant regulatory roles in virtually all cellular processes. The num-
ber of different types of posttranslational modification (PTM) known 
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associated with pathological states. For information linking genes to 
human diseases, useful starting points are the manually curated 
summaries within NCBI Gene (Summary and Phenotypes sections), 
OMIM (Gene Function section), and UniProt (Involvement in dis-
ease section). Supplementing these are more specialized resources 
linking genetic variations and expression abnormalities to clinical 
conditions. Although efforts are underway to standardize such data 
and centralize them in a single portal such as the NCBI’s ClinVar 
(Landrum et al., 2014), the current diversity of complementary dis-
ease resources means that these still warrant separate descriptions.
A comprehensive categorization of associations between human 
genes and diseases is provided by the Genetic Association Data-
base (Becker et al., 2004; Supplemental Table S15). Querying by 
gene term generates a table of published instances in which the 
involvement of that gene in a disease has been tested. Each entry 
reports the disease name and class and associated terms, plus nu-
merous links, including one to the corresponding publication, often 
with a one-line summary of the study’s conclusions. For well-studied 
genes the full output may contain considerable redundancy, and the 
database also reports negative associations (i.e., when a gene–dis-
ease association was tested and not found to exist), although these 
can be filtered from the output. Another valuable resource linking 
genes to diseases is KEGG (Kanehisa et al., 2014), in which a list of 
diseases associated with a gene of interest is shown in the relevant 
entry in the KEGG GENES database. Clicking a disease identifier 
links to the relevant entry in KEGG DISEASE, providing a full de-
scription of that disorder, the nature of the genetic association, etio-
logical factors, and molecular markers, plus pharmacological agents 
with which it can be treated. The Comparative Toxicogenomics 
Database (Davis et al., 2013) incorporates a complementary ap-
proach: in addition to recording associations between genes and 
disease from manual curation, this resource contains gene–disease 
associations inferred on the basis of reported interactions between 
gene products and compounds and between compounds and dis-
ease. Inferences are given a score that is used to rank the (often 
long) resultant list of gene–disease associations.
Two broad classes of genetic disease in which connections be-
tween variations and symptoms have been most closely studied are 
developmental disorders and cancer. For the former, searching the 
DECIPHER resource (Bragin et al., 2014) by gene name generates a 
table that lists documented occurrences of consented patients har-
boring variations in that gene, the relevant variations, and descrip-
tions of associated phenotypic symptoms. Clicking a record reveals 
more information about the patient, plus a genome browser indicat-
ing the position of the relevant variation relative to genes and other 
features.
The most intensely studied class of disease at the molecular level 
is almost certainly cancer, and probably the most comprehensive 
resource of somatically acquired genetic variations linked to human 
neoplasms is COSMIC (Forbes et al., 2011). For a given gene, an 
overview page contains an embedded genome browser providing a 
graphical summary of cancer-linked variations. Further gene-related 
information includes a breakdown of variation types, their distribu-
tion in different tissues, tables of specific mutations, and histograms 
of mutation frequency within protein domains, as well as lists of rel-
evant studies and literature references. Cancer cells harboring muta-
tions in certain genes may exhibit altered sensitivity to particular 
pharmaceutical agents. When appropriate, such drugs are listed, 
linking to their relevant entries in the Genomics of Drug Sensitivity 
in Cancer (GDSC) resource (Yang et al., 2013), providing interactive 
graphical representations of a wealth of data relating to drug sensi-
tivity and biomarkers.
Another approach to determining whether a protein may be post-
translationally modified is the use of PTM predictors. These pro-
grams scan a protein’s sequence, scoring each residue as a candidate 
for modification based on quantitative evaluation of the match be-
tween the sequence immediately surrounding the residue and pat-
terns of amino acid preferences of modifying enzymes for substrate 
targeting. Such analyses can provide helpful indications as to which 
residues of a protein might be modified, together with suggestions 
of enzymes capable of catalyzing the addition. Nevertheless, this ap-
proach is ultimately limited, as the sequence preferences of many 
modifying enzymes are unknown, and these programs rarely con-
sider additional crucial determinants such as longer-range enzyme–
substrate contacts and the combination of spatial and substrate ex-
clusivity (Alexander et al., 2011). PTM predictors have been discussed 
and evaluated (Eisenhaber and Eisenhaber, 2010; Que et al., 2010).
QuESTION 8: HAVE gENETIC VARIATIONS TO THIS HIT 
BEEN REPORTEd, ANd ARE THEy ASSOCIATEd WITH 
HumAN dISEASE PROCESSES?
Mutations and structural variations
The identification of genetic variations giving rise to distinct pheno-
types is of course a cornerstone of the genetic approach to under-
standing biological processes. Genetic variations range in scale 
from one-base-pair SNPs, to genomic structural variations (GSVs) of 
tens to millions of base pairs, to complete gene deletions or knock-
outs. Observed phenotypes resulting from such variations depend 
on the biological conditions used by researchers to assay and char-
acterize the variant cells and organisms and can range from the 
loosely descriptive to the highly quantitative. Such phenotypic data 
can be presented in a variety of formats, including text, tables, mul-
tidimensional images, and videos, all of which can be incorporated 
into modern Web-based gene resources.
For well-studied organisms, much relevant information on ge-
netic variations and corresponding phenotypes is present in 
species-specific gene databases (Supplemental Table S1), and so 
for exploring known variations in hits from model experimental or-
ganisms and their biological consequences, the relevant gene page 
from such a resource is often the best place to start. More compre-
hensive, multispecies repositories of genetic variations are stored in 
specialist resources such as dbSNP for SNPs (Bhagwat, 2010) and 
DGVa and dbVAR for GSVs (Lappalainen et al., 2013; Supplemental 
Table S14). Information from these and other sources is available via 
Ensembl, for which gene pages can be accessed from multiple ID 
types. In the relevant Ensembl gene page, under Gene-based dis-
plays, one option is the Variation table; this provides an overview of 
all genetic variations identified for that gene. Here initially types of 
variation are listed, each accompanied by a brief description and 
the number of times a variation of that type has been found in the 
gene of interest. Clicking Show for a variation type opens a table 
displaying full information about all occurrences for that gene.
At the protein level, reviewed UniProt entries list documented 
amino acid variants under the Sequence annotation (Features) sec-
tion, within three categories: Alternative sequence, Natural variant, 
and Mutagenesis. Alongside each variant are links to literature and 
source databases (where appropriate) and a graphic illustrating the 
position of the variation within the protein. When the variant has func-
tional or pathological consequences, these are briefly described.
Association with human diseases
A major motivation for studying many biological processes is to gain 
insight into causes of human disease, and thus it is often of interest 
to establish whether genes or proteins of interest are reported to be 
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less than half of these being associated with disease (Hopkins and 
Groom, 2002). Despite this limitation, the potential of gene prod-
ucts to be inhibitable is relevant, as it could be a factor for deciding 
which hits from a screen are deemed interesting for follow-up stud-
ies. For gene products with characterized three-dimensional struc-
tures, the DrugEBIlity resource takes a domain-based approach, 
using algorithms to assess multiple PDB records for the likely pres-
ence of binding sites for Ro5-compliant molecules. Querying by 
UniProt ID reveals a protein page showing sequence and domain 
information, followed by Tractability and Druggability scores, 
combined into an overall Ensemble Druggability assessment. The 
canSAR resource offers a complementary functionality, providing for 
a given protein a table of druggable or tractable domains, linking to 
diagrams detailing the interactions between these and relevant li-
gand molecules.
The set of possible combinations between proteins and small-
molecule compounds recorded in public databases presents billions 
of potential docking interactions, a large proportion of which are 
uncharacterized, many possibly harboring significant pharmaceuti-
cal potential. Massive in silico efforts are underway to assess these 
potential interactions, and the recently launched Drugable portal 
allows access to data relating to compounds predicted to dock 
with each target protein, correlated with tissue-expression profiles 
(Reardon, 2013).
QuESTION 10: I WOuLd LIkE TO kNOW EVERyTHINg 
ABOuT THIS gENE (OR PROTEIN)! HOW CAN I ACCESS 
AS muCH RELEVANT INfORmATION AS POSSIBLE?
The primary bioinformatic databases described so far provide a 
wealth of data relevant to the gene or protein of interest, but for the 
information-hungry biologist, visiting each site in turn is not likely to 
be the most efficient way of accessing these resources. A more ef-
fective approach is to perform a cross-database search (which que-
ries multiple resources in parallel, generating many outputs) or to 
access a summary website (which provides an overview of informa-
tion gathered from primary database resources).
Both the NCBI’s “GQuery” Global Cross-Database Search and 
the EBI Search (also known as EB-eye) allow the user to query all of 
their hosted databases in one operation; these multisearches can be 
initiated via a direct Web link (Supplemental Table S17). In both 
cases, for each database the number of hits is shown, alongside links 
to results lists for that database. The Bioinformatic Harvester (Liebel 
et al., 2005) is a utility that launches searches of multiple resources 
simultaneously, retrieving information about the gene or protein of 
interest from human, mouse, rat, zebrafish, or Arabidopsis. Queries 
of any type (names or IDs of genes or proteins, or any text term) are 
first used to generate a list of relevant proteins (IPI identifiers and 
one-line descriptions). On selection of a protein, Bioinformatic Har-
vester performs the searches, displaying results from each resource 
in a separate frame, helpfully organized in a multitabbed Web page. 
A subsequent project from the Harvester team demonstrated a 
proof-of-principle that all publicly accessible scientific data from lit-
erature, databases, and laboratory-hosted Web pages could be 
made accessible via a Google-style interface, using distributed 
search engine technologies (Lütjohann et al., 2011). Resources such 
as these, which would grow as more data sets are linked, may evolve 
into invaluable additions to the data-mining toolkit in the future.
Even with multisearch approaches such as these, exploring each 
resource to retrieve relevant information can involve much effort. 
More convenient are the overviews of genes and their products pro-
vided by summary websites, which compile relevant information for 
display in an easily readable manner (Supplemental Table S18). For 
QuESTION 9: ARE INHIBITORS Of THE gENE PROduCT 
kNOWN, ANd IS THE gENE “dRuggABLE”?
The ability of a gene product to be specifically and potently inhib-
ited by a small-molecule inhibitor provides great potential for its 
biochemical activities to be studied in vitro and for establishing its 
involvement in biological processes in cells and in vivo systems. 
Blocking the action of specific proteins involved in pathological pro-
cesses is of course one principal means of treating disease.
For a drug or chemical database to be useful for biological data 
mining, it must be queryable on the basis of target IDs, using stan-
dard gene or protein nomenclature. One such resource is ChEMBL 
(Bento et al., 2014), a database of bioactive small molecules (Sup-
plemental Table S16). Because dozens or hundreds of interacting 
molecules may be recorded for a given target, ChEMBL provides 
interactive graphs displaying distributions of their properties, allow-
ing the user to narrow a set of compounds for examination. Selected 
compounds are presented in a sortable table, which includes struc-
ture diagrams, physicochemical properties, and results of relevant 
bioassays. Another such resource is DrugBank (Law et al., 2014), a 
comprehensive database of pharmaceuticals and inhibitors. When a 
protein is recorded as a target of such a molecule, a UniProt ID-
based search reveals protein information, followed by a table of rel-
evant interacting molecules, each being a link to the full record from 
the main database.
The Comparative Toxicogenomics Database records links be-
tween genes and interacting chemicals, including effects of com-
pounds on the expression of genes, as well as the activities of their 
products. Each gene page displays the top 10 interacting chemicals 
(by number of literature references) in a bar chart. Clicking a chemi-
cal name opens a list of corresponding interactions; alternatively, 
clicking the Chemical Interactions tab opens a large sortable table 
of all interacting chemicals, with one-line descriptions of each inter-
action, plus literature references.
The canSAR resource (Bulusu et al., 2014) integrates gene, pro-
tein, functional, and chemical interaction information from numer-
ous sources. Following a target search, its Screening & Chemistry 
output displays interactive pie charts allowing the user to filter inter-
acting compounds on the basis of bioactivity type (binding, inhibi-
tion, etc.). Compounds can also be filtered by the number of their 
physicochemical properties that fit with the Rule of Five (Ro5), used 
as a rule of thumb to judge a molecule’s likelihood of being a suc-
cessful oral in vivo pharmaceutical agent (Lipinski et al., 1997). Click-
ing Inspect after applying a filter leads to a series of interactive 
graphs relating to this subset of chemicals, including scatter plots of 
physicochemical properties, plus a sortable table of chemical struc-
tures, properties, bioassay results, and literature references.
An alternative approach to retrieving such information is to 
search a database of assays involving compounds and targets, such 
as PubChem BioAssay (Wang et al., 2014). Querying this resource 
generates a list of titles of biological assays (but not compound 
names) in which the query gene or protein was a target, plus litera-
ture references. Results can be refined with a single click—for ex-
ample, to select those in which compounds inhibited with submicro-
molar (or subnanomolar) IC50 values. Each title links to a full record 
of information about the assay protocol, compounds used, and re-
sults; each compound links to its entry in the PubChem Compound 
database (Wang et al., 2009), where full chemical data are displayed, 
and the molecule’s structure can be visualized in a 2D or 3D viewer.
Returning to the gene product, the term “druggability” refers to 
“the likelihood of being able to modulate a target with a small-
molecule drug” (Owens, 2007). It is estimated that only 1/10 of hu-
man genes encode products that are potentially druggable, with 
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navigation via tabs and sections. For human 
genes, GeneCards (Stelzer et al., 2011) 
presents a compilation of properties and 
functions of the gene of interest (and prod-
ucts) from numerous primary bioinformatic 
sources in a long scroll-down format. This 
output includes functional summaries from 
NCBI Gene and UniProt, genomic and ex-
pression data, and links to commercial re-
agents such as recombinant proteins, anti-
bodies, inhibitors, and oligonucleotides for 
RNAi. A complementary functionality for hu-
man proteins is performed by neXtProt 
(Gaudet et al., 2013), which collates and 
summarizes a wealth of properties in an in-
formation-packed multitabbed format.
QuICk LINkS fROm HITS TO 
INTERNET-BASEd RESOuRCES
The answers to the foregoing 10 questions 
describe only a small selection of the doz-
ens or hundreds of freely accessible bioin-
formatic databases available. However, free 
and user-friendly software specifically de-
signed to allow quick access to relevant en-
tries within these resources from results ta-
bles is not commonplace. One method 
allowing easy and direct access to appropri-
ate entries within bioinformatic resources is 
the creation of a hyperlinked results table 
(Figure 2). Because all major spreadsheet 
programs allow the generation of hyperlinks 
incorporating contents of cells within the 
table, additional columns can be created 
containing custom hyperlinks that use hit-
based gene, nucleotide, or protein identifi-
ers, allowing users one-click direct access to 
relevant pages within Web-based resources. 
The creation of these hyperlinks is straight-
forward (Supplemental Method S1) and can 
be automated within most spreadsheet pro-
grams, thus negating the requirement for 
specialist data-mining software.
Online databases may be based around 
DNA, transcript, or protein IDs, with the ma-
jority using either gene symbols/codes or 
protein (UniProt) IDs, although some can be 
accessed using several ID types. To maxi-
mize the available options of resources di-
rectly accessible from results tables, a worth-
while exercise is to obtain gene symbols for transcripts or protein 
hits (Supplemental Method S2) or to obtain UniProt IDs for gene or 
transcript hits (Supplemental Method S3).
Clearly, with such a large number of online databases for which 
hyperlinks can be made, users should develop a familiarity with re-
sources available for their given organism and make the hyperlinks 
targeted for that species and relevant to the biological questions 
being investigated.
dATA SET–WIdE INfORmATION RETRIEVAL
Hyperlinked results tables allow one-at-a-time direct access to 
relevant information for each hit, but for larger sets of hits a more 
EBI Search results, alongside the listing of the number of hits in each 
database is the EBI Gene & Protein Summary. This provides a use-
ful overview of the properties of a gene and its products, within five 
tabs: gene, expression, protein, protein structure, and literature (for 
five species: human, mouse, budding yeast, Drosophila, and 
C. elegans). InterMine database technology integrates information 
about genes and proteins from multiple sources (Smith et al., 2012) 
and powers overview facilities for several experimental species 
via a series of interconnected Web portals: FlyMine, YeastMine, 
MouseMine, RatMine, ZebrafishMine, metabolicMine (including hu-
man genes), and modMine (flies and worms). These sites provide a 
fairly comprehensive distillation of functional information, with clear 
FIGURE 2: Approaches for obtaining functional information about experimentally identified 
gene, transcript, or protein hits. Freely available software tools can be used to obtain 
information about features and functions of genes, transcripts, or proteins in a results table from 
multiple sources. Generation of an interaction network shows at a glance the nature of any 
previously reported interactions between members of a set of hits, each of which can be 
explored using the resources indicated. Making a hyperlinked results table allows one-click 
access from each hit directly to relevant pages from a wide range of resources. Creating an 
annotated results table containing controlled-vocabulary terms or keywords from a range of 
sources allows hits to be classified and sorted on the basis of these terms. Step-by-step 
protocols for performing these analyses are presented in the Supplemental Materials.
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are performed using bioinformatics enrichment tools. Discussion 
and comparison of such programs is beyond the scope of this article 
and is the subject of recent reviews (Hedegaard et al., 2009; Huang 
da et al., 2009a; Hung et al., 2012; Kouskoumvekaki et al., 2013).
fuNCTIONAL ExPLORATION Of CELL PROLIfERATION 
fACTORS
The resources described here were applied to a hypothetical data 
set of 20 factors regulating aspects of cell proliferation: DNA replica-
tion, cell division, and genome stability. A hyperlinked table uses 
these factors to provide direct access to a selection of resources 
(Supplemental Table S20), which readers are invited to try out and 
compare to assess their suitability for their own research projects. 
Although no attempt is made to comprehensively report and evalu-
ate the outputs of these resources, their application to the 20 cell 
proliferation factors (in particular p53) highlighted issues relating to 
resource utility for the following aspects of gene or protein function.
Ontology annotation. The factors were analyzed for ontology 
terms in an attempt to retrieve straightforward descriptions of their 
functions. One-at-a-time searching using QuickGO returned GO 
terms for all 20 factors in all three categories. For p53, this yielded 
97 distinct terms for biological process, 28 for molecular function, 
and 16 for cellular component. DAVID returned even more (213, 31, 
and 24, respectively), as its GO output covers a full range of 
hierarchical levels. The large volume of p53 annotations, albeit 
comprehensive, appeared in places contradictory (positive and 
negative regulation of apoptosis), redundant (ion binding, cation 
binding, zinc ion binding), and overwhelming (localization to 
seemingly every subcellular structure). Thus, valid although these 
assignments may be, they are meaningful only in their biological 
contexts. Aiming for a more efficient approach, annotation of the 20 
factors with GO-slim terms was tried using PANTHER. This software 
recognized 17 of the proteins, provided GO-slim and protein-class 
annotation for 15, pathway terms for 5, and cell-component 
information for 1. This highlights issues encountered with ontology 
analysis: retrieval of comprehensive information may be useful for 
computational classification, but for human-readable summaries 
current outputs may appear both incomplete and too complete.
Protein–protein interactions. Analysis of the 20 factors using 
STRING revealed that they form an interconnected interaction 
network (Figure 2). Choosing the “more” option expanded the 
network, introducing further factors recognizably involved in 
regulating cell proliferation. For p53, IntAct and BioGRID retrieved 
>500 interacting proteins (somewhat overwhelming network 
diagrams!), making the task of establishing which are biologically 
important a major challenge. Some indication of interaction 
significance was provided by table ranking (IntAct by confidence, 
BioGRID by reporting frequency); for both resources, p53’s top 
interactor was MDM2, its best-characterized regulator. However, 
which of the 500 are biologically validated, play roles in p53-
mediated pathways, and regulate cell proliferation? Addressing 
such questions requires exploration beyond primary databases, 
integrating several data sources using more sophisticated software 
tools.
Protein feature identification. The outputs of eight protein feature 
annotation programs were assessed using p53, a transcription factor 
with three functional domains (N-terminal transactivation, central 
DNA binding, C-terminal tetramerization), plus sites of interaction 
with ions, DNA, and regulatory proteins. All three domains are 
efficient approach for obtaining and managing such information is 
the annotated results table (Figure 2). Here additional columns are 
created containing pertinent information for each hit, such as ontol-
ogy terms, protein domains and features, and pathways. Once in 
this format, hits can be easily sorted and categorized on the basis of 
these properties (e.g., using the AutoFilter facility within Excel 
[Microsoft, Redmond, WA]). It is also perfectly feasible to create a 
results table including multiple hyperlinks and annotation columns.
Several Web-based programs accept the input of multiple gene, 
nucleic acid, or protein IDs (with ID conversion if necessary), forming 
a table with additional columns containing feature annotations (Sup-
plemental Table S19). These tables can be easily exported and inte-
grated with the original results spreadsheet to form an annotated 
results table. PANTHER’s Gene List table provides annotation with 
GO-slim terms in the three categories, plus its own Protein class and 
Pathway terms. DAVID (Huang da et al., 2009b) generates a Func-
tional Annotation Table containing full GO terms, OMIM diseases, 
InterPro and SMART features, and BioCarta and KEGG pathways. 
UniProt’s Results table can be customized with additional annota-
tion columns including keywords, protein domains, disease associa-
tions, PubMed references, and even the full amino acid sequence. 
Step-by-step procedures for generating annotated results tables us-
ing these three resources are provided in Supplemental Methods 
S4–S6.
It is sometimes desirable to generate a visual representation of 
domains and other features for a set of proteins by inputting their 
IDs in batch rather than one at a time (as described for Question 5). 
The CDD provides for the submission and analysis of multiple pro-
teins, allowing one-at-a-time display of domain structures, motifs, 
and key residues. In contrast, SMART allows input of many protein 
IDs, displaying their domains and features in a scroll-down multiple-
protein view.
One useful approach to assessing known relationships between 
gene products in an experimental data set is the interaction net-
work diagram (Figure 2). This can be created using STRING, in 
which, after the input of a hit list, a network diagram is generated 
with connections color coded by interaction type (Supplemental 
Method S7). This analysis provides an at-a-glance display of which 
subsets of genes or proteins share membership of complexes or 
systems. Each protein links to several database resources, and the 
page contains links to data set–wide overviews of occurrence (gene 
conservation), coexpression, and evidence for the mutual associa-
tion of subsets of factors within the data set. Complementing this, 
input of gene, transcript, or protein hits to DAVID generates an An-
notation Summary Results page with a Pathways subsection. Here 
the presence of one or more gene products from the input list within 
various pathways (from resources including BioCarta, KEGG, and 
Reactome) is indicated, and pathway diagrams can be displayed 
with the relevant proteins highlighted and flashing. More sophisti-
cated analyses of the properties of a set of interacting gene prod-
ucts are possible using the Cytoscape network visualization and 
analysis software (Smoot et al., 2011). A large range of apps 
(formerly called plugins) is readily available, providing a huge reper-
toire of visualization and analysis options, including the integration 
of information from other data sets and annotation sources, and 
statistical analyses (Saito et al., 2012; Lotia et al., 2013).
After the retrieval of functional information about a set of experi-
mental genes, transcripts, or proteins, a further analytical step could 
be to deduce which of their properties or ontology terms are en-
riched relative to a background data set, thus giving an indication of 
which classes of gene or protein or biological systems are overrep-
resented and thus predominate within the data set. These analyses 
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1) free: publicly available, cross-platform, and open source, with da-
tabase architecture and algorithms described in peer-reviewed pub-
lications; 2) comprehensive: able to draw on a wide variety of lead-
ing database resources; 3) updated: regularly, coordinated with 
releases of major sequence and functional databases; 4) smart: ca-
pable of automatically recognizing ID types and thus determining 
the relevant species and relationships between genes and their 
products; and 5) flexible: allowing a choice of analytical methods 
and output formats.
Continued increases in database comprehensiveness, usability, 
and integration can be expected in the future and are to be wel-
comed. So many genes and their products have undergone some 
degree of characterization, and so many biological processes have 
begun to be described in molecular terms, yet there remain a great 
many genes bearing the “uncharacterized” label. Thus, for research-
ers whose projects involve the discovery of genes, transcripts, or 
proteins and their functional characterization, with all the database 
resources available, paradoxically their most interesting hits may be 
the ones for which there is the least information to be found.
represented by Pfam and reflected in the outputs of Gene3D, 
InterPro, CDD, Dasty, and Annie, with only the central Pfam domain 
appearing in ELM. Gene3D identifies two domains based on 
structure, but SMART only a “low-complexity region.” In addition, 
manually curated annotations of experimentally determined 
functional regions and sites proved invaluable. CDD displays p53’s 
dimerization, DNA-binding, and zinc-binding sites, whereas ELM 
indicates docking sites for MDM2 and cyclins, plus verified nuclear 
localization and export sequences. Dasty in addition shows UniProt-
curated regions of p53 required for binding physiological interactors. 
Thus information from each resource is different and complementary, 
and ideally all should be consulted to obtain the maximum 
information.
CONCLuSIONS ANd PERSPECTIVES
Modern research biology increasingly relies on projects that use 
data derived from genome sequencing to make discoveries. The 
past decade saw a huge increase in the generation of sequence and 
experimental data, as well as in the number of databases relating to 
gene and protein sequence and function. A major challenge that 
has arisen is finding means of making optimal use of these resources 
to characterize and explore hits from larger-scale data sets in a way 
that makes sense to the research biologist and ultimately leads to 
discoveries of significance to the scientific community.
The enhancement of plain data spreadsheets to generate hyper-
linked and annotated results tables is a flexible and universally ap-
plicable approach that facilitates the exploration and characteriza-
tion of experimental hits from discovery projects. This procedure is 
relatively easily integrated as a last step in analytical workflows, us-
ing, for example, macros in Excel and online tools such as DAVID. 
For analytical service providers such as genomics, proteomics, and 
screening platforms, such enhancements give added value to the 
products they provide. For researchers, the presence of such links 
and annotations gives them the opportunity to easily categorize ex-
perimental hits on the basis of biological properties and allows them 
to pursue their curiosity as far as online resources allow.
The rise in recent years of several independent database re-
sources covering the same territory has in many cases led to increas-
ing data standardization and exchange. This period has also seen 
the emergence of meta-databases, cross-database search engines, 
and overview sites providing unified portals for information re-
trieval—resources particularly beneficial for researchers exploring 
hits from larger-scale studies. This being the case, support for ex-
pert-curated primary databases is still vital, as these remain the cru-
cial points of contact with data-providing research teams and retain 
responsibility for data curation, quality control, and ensuring that 
connections are maintained between online data and peer-reviewed 
publications.
Cross-database searches such as those from the NCBI and the 
EBI and the Bioinformatic Harvester can query dozens of resources, 
identifying hundreds of relevant entries. Internet-wide search tools 
can query thousands of sources, potentially retrieving billions of 
documents and data files. Evidently, as the rapid expansion of data 
continues, the danger increasingly looms of encountering a “too 
much information” situation. The challenge for developers of infor-
mation-retrieval software will inevitably shift from enabling access to 
ever-larger data quantities to ensuring that data are delivered in a 
meaningful way: organized, categorized, and presented such that 
they can be interpreted and evaluated by researchers worldwide.
Although various programs are available for exploring the prop-
erties of sets of genes, transcripts, and proteins, the ideal software 
tool, in my opinion, has yet to be created. Such software would be 
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